26 results
8-K
EX-99.1
CADL
Candel Therapeutics Inc
28 Mar 24
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
7:45am
insurance and recruiting costs, which were partially offset by increased employee-related expenses. General and administrative expenses included non
8-K
EX-99.1
CADL
Candel Therapeutics Inc
10 Aug 23
Candel Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
8:15am
of 2022. The decrease was primarily due to lower recruiting and insurance costs, partially offset by an increase in professional service
8-K
EX-99.1
vlsgykbulfrqsa
11 May 23
Candel Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:31am
S-3
c55j8wr5duxl8o69
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
c7kql57c
5 Aug 22
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:30am
10-K
2qp09y dbj
29 Mar 22
Annual report
8:46am
10-Q
78a5a177 4ksj7xtwowy
8 Sep 21
Quarterly report
8:37am
424B4
98x2usmkyyf
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.9
iuks1t7txzm4qxx29j
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.10
snd7ys 3d
16 Jul 21
IPO registration (amended)
6:07am